Cash & equivalents increased 200.9%
Cash & equivalents changed +200.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +200.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Noncurrent long-term debt changed +111.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +42.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating cash flow changed +41.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Shares outstanding changed +20.9% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Operating income changed +33.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capital expenditure changed -94.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed -40.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Shares outstanding changed +20.7% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.